BackgroundBreast and gynecological cancers are often hormone dependent. The role of reproductive factors and endogenous hormones in tumorigenesis of these tumors has been investigated in numerous studies. Safety of oral contraception, hormone therapy during perimenopause or postmenopause or fertility treatment is of special interest for the information of women who are planning to use these therapies.